Larson Financial Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Larson Financial Group’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.46K	Sell	22 -1	-4%	-$284	﹤0.01%	2650
2026 Q1	$6.41K	Buy	23 +17	+283%	+$4.9K	﹤0.01%	2480
2025 Q4	$1.82K	Sell	6 -19	-76%	-$5.93K	﹤0.01%	2802
2025 Q3	$7.01K	Sell	25 -2,114	-99%	-$575K	﹤0.01%	2210
2025 Q2	$516K	Buy	2,139 +307	+17%	+$72.6K	0.02%	424
2025 Q1	$446K	Buy	1,832 +689	+60%	+$207K	0.02%	430
2024 Q4	$375K	Buy	1,143 +119	+12%	+$40.4K	0.02%	423
2024 Q3	$343K	Buy	1,024 +703	+219%	+$223K	0.02%	434
2024 Q2	$87.7K	Buy	+321	New	+$93.4K	0.01%	680

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Larson Financial Group's BIO Position: Q2 2026 in Review

Larson Financial Group reduced its Bio-Rad Laboratories Class A (BIO) stake by 4.3% in Q2 2026, selling an estimated $284 and leaving 22 shares worth $6.46K. The position accounts for ﹤0.01% of the portfolio, ranked #2650.

Larson Financial Group first reported a position in BIO in Q2 2024 and has held it in 9 quarters since. The position peaked at $516K in Q2 2025. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Larson Financial Group held 22 shares of Bio-Rad Laboratories Class A worth $6.46K as of Q2 2026.
Larson Financial Group sold 1 Bio-Rad Laboratories Class A share in Q2 2026, an estimated $284.
Bio-Rad Laboratories Class A made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2650 holding.
Larson Financial Group first reported a position in Bio-Rad Laboratories Class A in Q2 2024 and has held it in 9 quarters since.
Larson Financial Group's Bio-Rad Laboratories Class A position peaked at $516K in Q2 2025.
398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.